Physician profile
Stanley D Herrell
NPI 1972690089
$14,634.75
in general payments reported to CMS, 2019-2025
10 companies · $224 in 2025
The $224 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $3,592 · 2021: $195 · 2022: $295 · 2023: $3.82 · 2024: $64.81 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $289 · Education: $3.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $288.89 |
| Education | $3.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galil Medical INC. | $9,631.08 | 2019 | |
| Boston Scientific Corporation | $3,974.92 | 2019-2022 | |
| Intuitive Surgical, INC. | $368.98 | 2019-2021 | |
| Photocure INC | $149.19 | 2025 | Cysview |
| Conmed Corporation | $137.47 | 2019 | |
| Astellas Pharma US INC | $122.13 | 2020-2022 | |
| Biocompatibles, INC. | $107.46 | 2019 | |
| Karl Storz Endoscopy-America | $74.89 | 2025 | Image1 S Connect |
| Procept Biorobotics Corporation | $64.81 | 2024 | Aquabeam System |
| Travere Therapeutics, INC. | $3.82 | 2023 | Thiola |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Herrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.